An alternate pathway to androstenedione synthesis by human adrenals: evidence of a balance in 11 beta-hydroxylase and 17,20-lyase activities leading to androstenedione.
Until now, dehydroepiandrosterone and 17-hydroxyprogesterone were thought to be the main precursors for the synthesis of androstenedione by the human adrenal cortex. However, secretion of androstenedione and 11-deoxycortisol are increased when 11 beta-hydroxylase activity is impaired, e.g. by metyrapone test or by congenital adrenal hyperplasia resulting from 11 beta-hydroxylase deficiency. The present study with human adrenals shows that 11-deoxycortisol, the precursor of cortisol synthesis, is also a precursor of androstenedione in humans. Our data show that androstenedione synthesis is inversely related to the synthesis of cortisol and cortisone. This new pathway is thus triggered by a lower activity of 11 beta-hydroxylase that is responsible for the last step of cortisol. Indeed, when the activity of this enzyme is impaired, 11-deoxycortisol follows the pathway that leads to androstenedione synthesis in the adrenals. These data, together with the increase in ACTH secretion, may explain the increased androstenedione plasma levels observed in patients with congenital adrenal hyperplasia caused by 11 beta-hydroxylase deficiency and in patients given inhibitors of 11 beta-hydroxylase for therapeutic purposes.